Special Survey Long-term Treatment With Tiotropium on COPD
Special Survey Long-term Treatment
Sponsor: Boehringer Ingelheim
Listed as NCT00638183, this observational or N/A phase trial focuses on Pulmonary Disease, Chronic Obstructive and remains completed. Sponsored by Boehringer Ingelheim, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Apr 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Asahikawa, Japan , Chikushino-shi, Japan , Daitō, Japan , Ebina, Japan , Echizen, Japan , Fukui, Japan , Fukushima, Japan , Funabashi, Japan , Gosen, Japan , Habikino, Japan and 79 more locations